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Conventional affinity purification followed by mass
spectrometry (AP-MS) analysis is a broadly appli-
cable method used to decipher molecular interaction
networks and infer protein function. However, it is
sensitive to perturbations induced by ectopically
overexpressed target proteins and does not reflect
multilevel physiological regulation in response to
diverse stimuli. Here, we developed an interface be-
tween genome editing and proteomics to isolate
native protein complexes produced from their natu-
ral genomic contexts. We used CRISPR/Cas9 and
TAL effector nucleases (TALENs) to tag endogenous
genes and purified several DNA repair and chro-
matin-modifying holoenzymes to near homogeneity.
We uncovered subunits and interactions amongwell-
characterized complexes and report the isolation of
MCM8/9, highlighting the efficiency and robustness
of the approach. These methods improve and sim-
plify both small- and large-scale explorations of pro-
tein interactions as well as the study of biochemical
activities and structure-function relationships.
INTRODUCTION
The cell is composed of a collection of protein machines res-
ponsible for the coordinated execution of cellular functions
(Alberts, 1998). Deciphering the components and activities of
these molecular assemblies is crucial to understand the cellular
networks that are perturbed under disease states (Gavin et al.,
2011; Rolland et al., 2014). For example, the identification of can-
cer-driving mutations among a background of passenger muta-
tions can be improved by tying combinations of raremutations to
specific protein complexes (Krogan et al., 2015; Leiserson et al.,
2015; Rolland et al., 2014). Besides, the growing list of cancer-
related genes often comprises uncharacterized proteins for
which focused proteomic studies could help uncover function
(Lawrence et al., 2014; Vogelstein et al., 2013).
Affinity purification followed by mass spectrometry (AP-MS)
analysis is a powerful approach used to characterize protein-Cprotein interactions and multiprotein complexes that are defined
as sets of stably associated proteins isolated under standard-
ized biochemical conditions (Gavin et al., 2011). Landmark
studies describing genome-wide identification of complexes in
budding yeast generated high-quality datasets by relying on
two major technical innovations (Gavin et al., 2006; Krogan
et al., 2006). First, the development of standardized tandem af-
finity purification (TAP) protocols allowed the isolation of com-
plexes by sequential capture and elution using pairs of affinity
tags (Rigaut et al., 1999). Second, systematic tagging of open
reading frames on the chromosomes via homologous recombi-
nation permitted retention of the physiological regulation of
gene expression for the bait proteins.
While pioneering studies in Arabidopsis, Drosophila, and hu-
man cells using ectopic expression of tagged proteins have
yielded important insights into biological pathways in higher eu-
karyotes (Behrends et al., 2010; Goudreault et al., 2009; Guru-
harsha et al., 2011; Hegemann et al., 2011; Hutchins et al.,
2010; Huttlin et al., 2015; Marcon et al., 2014; Sardiu et al.,
2008; Sowa et al., 2009; Van Leene et al., 2010), there is a
need to keep improving thesemethods in order to reduce pertur-
bations in the stoichiometry of protein interactions and prevent
aberrant localization, protein aggregation, dominant-negative
effects, and toxicity (Doyon et al., 2011; Ho et al., 2002). For
example, chromatin-modifying complexes require meticulous
biochemical characterization, since they often exist in different
forms with paralogous subunits and only their native assembly
can recapitulate their specificity for a given histone residuewithin
chromatin (reviewed in Lalonde et al., 2014). Hence, we devel-
oped straightforward methods to streamline the mapping of
protein-protein interactions in human cells under settings mini-
mizing deviations from their natural context. We used engi-
neered nucleases such as zinc-finger nucleases (ZFNs), TAL
effector nucleases (TALENs), and CRISPR/Cas9 to simplify the
generation of cell lines with tailored modifications and enable
the expression of tagged proteins from their endogenous loci
(Hsu et al., 2014; Joung and Sander, 2013; Sternberg and
Doudna, 2015; Urnov et al., 2010). First, we exploited a genomic
safe harbor locus to rapidly and reliably generate cell lines ex-
pressing bait proteins at near-physiological levels as a surrogate
to classical plasmid- or virus-based methods for stable cell line
generation. Second, we introduced an affinity tag at the N and
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to retain the dynamic control of gene expression specified by the
native chromosomal context and the natural post-transcriptional
regulation mechanisms. Under these conditions, we obtained
near-homogenous preparations of native proteins complexes
in sufficient amounts to perform biochemical assays and identify
their subunits via mass spectrometry analysis. The tagged cell
lines were also used for immunoprecipitation of cross-linked
chromatin fragments (chromatin immunoprecipitation [ChIP]) to
study protein-DNA interactions in vivo under normalized condi-
tions. These tools were portable to numerous proteins and re-
present a general solution for protein isolation, complex identifi-
cation, and genome location analysis under physiological
conditions. Importantly, the scalability and adaptability of this
system will open avenues for the systematic and unbiased map-
ping of protein-protein networks in a variety of organisms.
RESULTS
Characterization of a Potent Tandem Affinity Tag
An ideal TAP tag leads to high recovery of a fusion protein pre-
sent at low concentration with minimal background contami-
nants. It should be functional as N- and C-terminal fusions and
its size and amino acid (aa) sequence should have no impact
on protein function. In preliminary experiments, we evaluated
several tags, including the AC-TAP, SBP, and FLAG-hemagglu-
tinin (FLAG-HA) tags, and settled on a combination of 3xFLAG
and 2xSTREP tags, as both tags can be eluted under gentle con-
ditions and yield to the isolation of highly purified material (see
below) (Doyon et al., 2006; data not shown). Our version contains
59 aa for a predicted molecular weight of 6 kDa and does not
necessitate proteolytic cleavage (Figure 1A).
To fine-tune our purification scheme, we selected the KAT5/
TIP60 tumor suppressor protein, the catalytic subunit of the
NuA4 (nucleosome acetyltransferase of histone H4) complex
that regulates gene expression and promotes DNA repair via
homologous recombination and is required for embryonic stem
cell self-renewal and differentiation (Steunou et al., 2014).
NuA4 is composed of more than 15 subunits ranging from 20
to 400 kDa in size (Cai et al., 2005; Doyon et al., 2004, 2006; Ikura
et al., 2000). We first established two independent pools of cells
expressing KAT5 fused to a C-terminal TAP tag and performed
purifications from whole-cell extracts to determine the proper
order of steps required to achieve high yields and purity. We
observed that the high binding capacity of the anti-FLAG M2
affinity resin is best used as a first step to recover the maximum
number of complexes while the Strep-Tactin resin dramatically
increases the purity of the final samples, yielding near-homo-
genous preparations from low amounts of starting material
(Figure S1).
TAP following Nuclease-Driven Gene Addition to the
AAVS1 Genomic Safe Harbor Locus
In order to rapidly generate isogenic cell lines expressing TAP-
tagged cDNAs, we used nuclease-driven targeted integration
into the human PPP1R12C gene, a safe harbor genomic locus
known as AAVS1 that allows stable transgenesis and neutral
marking of the cell (DeKelver et al., 2010; Hockemeyer et al.,
2009; Lombardo et al., 2011). This system is composed of a622 Cell Reports 13, 621–633, October 20, 2015 ª2015 The Authorsnuclease that cleaves the first intron of PPP1R12C and a gene-
trap vector allowing puromycin selection of targeted cells. We
adapted this system to integrate tagged cDNAs and used the
moderately active human PGK1 promoter to achieve slight over-
expression conditions (Figure 1A and see below). We targeted
two subunits of NuA4 to the AAVS1 locus and purified the asso-
ciated complexes. We chose the enhancer of polycomb homo-
log 1 (EPC1) and the E1A binding protein p400 (EP400) as model
proteins. Due to their size (100 and 400 kDa, respectively), we
reasoned that it would represent a substantial test for biochem-
ical stability during purification. Likewise, targeting required er-
ror-free ZFN-driven addition of their relatively large expression
cassettes of 4.3 kb and 11.3 kb.
K562 cells were selected as our model cell line because they
can be cultivated, expanded, and transfected with high effi-
ciency as suspension cultures. They are also permissive to
genome editing events and tolerate cloning via limiting dilution
or in semi-solid media. Moreover, as a designated tier 1 cell
line used by all investigators of the Encyclopedia of DNA Ele-
ments (ENCODE) project, a myriad of genomic and epigenomic
data is available for this cell line (ENCODE Project Consortium,
2012).
We first transfected K562 cells with AAVS1-targeting ZFNs
and theEPC1 donor and selected clones inmethylcellulose-con-
taining media supplemented with puromycin (Figure 1A). Single-
cell-derived colonies were picked after 10 days and expanded,
and transgene expression was monitored by western blot. In a
typical experiment, more than 90% of the clones expressed
the transgene with little variability (see Figure S1 for an example).
Nuclear extracts were prepared from an EPC1-tag cell line, as
well as from K562 cells expressing only the tag (mock), and sub-
jected to TAP. EPC1 complex subunits separated by SDS-PAGE
could be unambiguously identified on silver-stained gels due to
the very low protein background observed in the mock purifica-
tion after double-affinity purification (Figures 1B). Mass spec-
trometry analysis identified all known components of NuA4, in
addition to MBTD1, which was not previously ascertained as a
core complex subunit (Cai et al., 2005; Doyon et al., 2004,
2006; Ikura et al., 2000) (Table S1). Next, we performed a recip-
rocal purification of the complex by repeating the process with
EP400, coding for the large SWI/SNF2-family ATPase that incor-
porates histone variant H2A.Z into chromatin (Weber and Henik-
off, 2014). We obtained a complex that was indiscernible from
the EPC1 assembly (Figures 1C and 1D; Table S1). In contrast
to previously published data, the EP400 complex contains the
KAT5 catalytic subunit (Fuchs et al., 2001). It appears that over-
expression of EP400 that was achieved using retroviral-based
gene delivery in the previous study resulted in the purification
of a partially assembled complex.
An important characteristic of our system is that the purified
fractions can be assayed biochemically in vitro. To determine
whether the purified complexes are recovered in sufficient
amounts and concentration, we performed histone acetyltrans-
ferase (HAT) assays. We observed robust enzymatic activity for
both complexes with substrate specificity consistent with pub-
lished reports for KAT5/NuA4 (Doyon et al., 2004; Ikura et al.,
2000) (Figure 1E). Again, these observations contrast with the
minimal traces of HAT activity observed for the EP400 complex
Figure 1. ZFN-Driven Gene Addition to the AAVS1 Locus Simplifies Tandem Affinity Purification of Multisubunit Protein Complexes
(A) Schematic of the donor construct and of the AAVS1 locus following cDNA addition. The first two exons of the PPP1R12C gene are shown as open boxes. Also
annotated are the locations of the splice acceptor site (SA), 2A self-cleaving peptide sequence (2A), puromycin resistance gene (Puro), polyadenylation sequence
(pA), human phosphoglycerate kinase 1 promoter (hPGK1), and 3xFLAG-2xSTREP tandem affinity tag (Tag); homology arms left and right (HA-L, HA-R) are
respectively 800 and 840 bp. Sequence of the TAP tag. The 3xFLAG sequence is in bold, and 2xSTREP is in bold and underlined.
(B) Silver-stained SDS-PAGE showing the purified EPC1 complex. K562 cells expressing the tag (Mock) and a clonal cell line expressing EPC1-tag (EPC1).
(C) Silver-stained SDS-PAGE showing the purified EP400 complex from a clonal cell line expressing EP400 tag (EP400). Proteins were identified from un-
fractionated protein samples and assigned to specific gel bands based on extensive western blotting analysis.
(D) Western blots of selected NuA4 subunits on purified fractions.
(E) Autoradiogram showing the results of HAT assays to determine the specificity of the EPC1 and EP400 complexes. Coomassie staining was used as a loading
control for histones.
See also Figure S1.and the reported disconnection between these two enzymatic
activities (Fuchs et al., 2001; Park et al., 2010; Tyteca et al.,
2006). Taken together, these data demonstrate that coupling
our TAP approach with gene targeting at AAVS1 creates a highly
efficient surrogatemethod for the isolation of native protein com-
plexes under near-physiological conditions.CTAP of Native Multisubunit Protein Complexes following
CRISPR/Cas9-Driven Tagging of Endogenous Genes
Having demonstrated that our purification strategy worked effi-
ciently and eliminated most background contaminants at the
low expression levels obtained by targeting the AAVS1 locus,
we aimed to determine if proteins expressed from their naturalell Reports 13, 621–633, October 20, 2015 ª2015 The Authors 623
(legend on next page)
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chromosomal contexts could be isolated with high specificity as
physiologically regulated endogenous complexes. We designed
CRISPR/Cas9-based nucleases to cleave DNA at the vicinity of
the stop codon of EPC1 in order to stimulate homology-directed
integration of the TAP tag using a donor molecule containing
short homology arms (Figures 2A and S2). Following transfection
of K562 cells with the nuclease and recombination donor, we
readily detected the incorporation of the tag in the pool of cells
by PCR (Figure S3). Targeted clones, isolated by limiting dilution
in the absence of any selection, were observed at a frequency of
6% (10/165), and accurate gene modification was confirmed by
western blot analysis and sequencing (Figures 2B, 2C, and S3).
We did not obtain homozygous clones for this gene, but results
of our PCR analysis suggest that three copies of the locus are
present in K562 cells (Figure S3). Comparison of the EPC1-tag
protein levels expressed from the AAVS1 locus versus the
endogenous gene revealed an 2.5-fold overexpression in the
former case (Figures 2G and S3). We performed side-by-side
TAP from an endogenously tagged EPC1 cell line and from a
clone targeted at AAVS1 and observed matching banding pat-
terns on silver-stained gels (Figure S3). Mass spectrometry anal-
ysis confirmed the complete coverage of the subunits when the
complex is purified from the endogenous locus (Table S1). To
confirm these observations, we used a similar approach to
perform a reciprocal purification of the complex by tagging the
endogenous EP400 gene at its C terminus (Figures 2D and S2).
The efficiency of targeting in this case was 21% (13/61, including
2 homozygous clones). For the purification, a homozygous clone
expressing tagged EP400 was selected (Figures 2E, 2F, and S3).
This clone expressed 2-fold less protein than the one used in
the AAVS1 purification (Figures 2G and S3). Both complexes
could be purified to near homogeneity and displayed strong
H4/H2A-specific HAT activity toward nucleosomes (Figures 2H
and 2I; Table S1). Given that MBTD1 was reproducibly detected
in these preparations, we performed reciprocal tagging to
confirm its stable association with NuA4. CRISPR/Cas9-medi-
ated integration of the TAP tag at its C terminus was efficient
reaching 26% (20/78, including 6 homozygous clones) of posi-
tive clones (Figures S2; data not shown). Purification of MBTD1Figure 2. CRISPR/Cas9-Driven Tagging of NuA4 Subunits Enables R
Complexes
(A) Schematic of the EPC1 locus, Cas9 target site, and donor construct used to
positions of the stop codon (TAG), the protospacer adjacent motif (PAM) that sp
(B) Schematic and results of a PCR-based assay (out-out PCR) to detect targeted
by limiting dilution. Primers are located outside of the homology arms and are de
(C) Western blots showing EPC1-tag protein expression in K562 clones. Mock ind
FLAG M2 antibody was used to detect EPC1, and the GAPDH antibody was use
(D) Targeting scheme for EP400, depicted as in (A).
(E) Same as (B), but for EP400.
(F) EP400 expression monitored as in (C).
(G) 2-fold serial dilutions of whole-cell extracts prepared from AAVS1-EPC1/E
determine the relative expression of EPC1-tag proteins. Error bars indicate the S
(H) Silver-stained SDS-PAGE showing the purified EPC1 and EP400 complexes.W
EP400-tag (#43) from their endogenous loci.
(I) Autoradiogram showing the results of HAT assays to determine the specificity of
(J) Silver-stained SDS-PAGE showing the purified MBTD1 complex.
(K) Western blots of selected NuA4 subunits on purified fractions. Wild-type K562
assigned to specific gel bands based on extensive western blotting analysis.
See also Figures S2 and S3.
Cusing a homozygote clone confirmed its association with NuA4
(Figures 2J and 2K). Thus, our approach led to the most com-
plete characterization of native NuA4 components to date. Not
only we were able to conclusively demonstrate that EPC1 and
EP400 exclusively associate with the complex, but we also
identified MBTD1 as novel subunit. These data demonstrate
that highly efficient purification of native protein complexes
is achievable with minimal chromosomal sequence disruption
and preservation of endogenous physiological regulation of the
bait protein.
TALEN-Enabled Purification of the Endogenous
Polycomb Repressive Complex 2
To test the generality of the TAP procedure, we undertook the
purification of the enhancer of zeste homolog 2 (EZH2), the cat-
alytic subunit of the polycomb repressive complex 2 (PRC2)
responsible for the di- and tri-methylation of histone H3 at lysine
27 (H3K27me2/3), a histone mark that correlates with silent or
poorly transcribed genomic regions (Margueron and Reinberg,
2011). EZH2 is a critical regulator of development and controls
stem cells pluripotency and differentiation, and its deregulation
is at the center of novel therapeutic strategies for a variety of can-
cers (Plass et al., 2013). First, EZH2 with an N-terminal TAP tag
was targeted to the AAVS1 locus (Figure S1). Next, we replaced
the natural ATG of EZH2 with the TAP tag via homology-directed
repair at the chromosomal locus using a pair of TAL effector nu-
cleases (TALENs) (Figures 3A and S4) (Reyon et al., 2012). 21%
(20/96, including 6 homozygous clones) of screened clones had
a tagged allele as assessed by PCR, western blotting, and
sequencing (Figures 3B, 3C, and S4). A homozygote clone ex-
pressing exclusively the tagged EZH2 protein was selected for
TAP. Interestingly, in this context, the endogenous locus drives
higher protein expression levels as compared to the ectopically
expressed protein from the AAVS1 locus (Figure S4). The com-
plexes were isolated from nuclear extracts prepared from both
cell lines and analyzed by SDS-PAGE and silver staining. Both
preparations appeared similar, as a specific protein band pattern
could be clearly identified from the gels when compared to the
mock fractions (Figures 3D and 3E). Co-purified proteins wereeciprocal Tandem Affinity Purification of the Endogenous Native
insert the TAP tag to the C terminus of the EPC1 protein. Annotated are the
ecifies the cleavage site, and homology arms left and right (HA-L, HA-R).
integration (TI) of the tag sequence in single-cell-derived K562 clones obtained
signed to yield a longer PCR product if the tag is inserted.
icates cells treated with donor and Cas9 nuclease in the absence of gRNA. The
d as a loading control.
P400 and CRISPR-EPC1/EP400 cell lines were analyzed by western blot to
D from two independently performed experiments.
ild-type K562 cells (Mock) and clonal cell lines expressing EPC1-tag (#112) and
the complexes. Coomassie stainingwas used as a loading control for histones.
cells (Mock). Proteins were identified from unfractionated protein samples and
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Figure 3. Tandem Affinity Purification of the Native PRC2 Protein Complex
(A) Schematic of the EZH2 locus, TALEN target site, and donor construct used to insert an affinity tag to the N terminus of the EZH2 protein. Annotated are the
positions of the start codon (ATG), the left and right TALEN target sites, and homology arms left and right (HA-L, HA-R).
(B) Schematic and results of a PCR-based assay (out-out PCR) to detect targeted integration (TI) of the tag sequence in single-cell-derived K562 clones obtained
by limiting dilution following TALEN-driven gene targeting. Primers are located outside of the homology arms and are designed to yield a longer PCR product if the
tag is inserted.
(C) Western blots showing tag-EZH2 protein expression in K562 clones. Mock indicates cells treated with donor only. The FLAGM2 antibody was used to detect
EZH2 and the actin antibody was used as a loading control.
(D) Silver-stained SDS-PAGE showing the purified EZH2 complex expressed from the AAVS1 locus. K562 cells expressing the tag (Mock) and a clonal cell line
ectopically expressing tag-EZH2.
(legend continued on next page)
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analyzed by mass spectrometry, leading to the unambiguous
identification of all known PRC2 components (Table S2) (Mar-
gueron and Reinberg, 2011). Substoichiometric interactions
between PRC2 and the EHMT1/2 complex, a H3K9 mono- and
di-methyltransferase, were also detected in the TALEN-derived
clone (Figure 3F; Table S2). The interaction is not mediated by
co-localization/co-purification on DNA, since it is not sensitive
to treatment with benzonase (Figure S4). This association shows
a direct physical link that supports the concept of an H3K27me/
H3K9me switch for the long-term repression of differentiation
genes (Mozzetta et al., 2014). It also indicates that biallelic tar-
geting of endogenous genes, leading to exclusive expression
of the tagged bait protein in the cell, can reveal labile and impor-
tant interactions. Lastly, the purified fractions contained robust
enzymatic activity as determined by histone methyltransferase
(HMT) assays (Figure 3G).
Interactions between Endogenously TaggedChromatin-
Modifying Complexes and Genomic DNA Regions
ChIP is a powerful technique used to investigate the interaction
between proteins and DNA in the cell, permitting the identifica-
tion of genomic regions bound by a protein of interest. We tested
whether the endogenously tagged cell lines could be used for
ChIP using the well-characterized anti-FLAG M2 antibody and
analyzed the occupancy of tag-EZH2 and EPC1-tag to the
HOXA9 locus and RPL36AL ribosomal protein gene. We
observed strong binding of EZH2 at HOXA9, a bona fide PRC2
target, and marginal enrichment at RPL36AL (Figure 3H). In
contrast, EPC1 was specifically recruited to the highly tran-
scribed RPL36AL gene, as expected for NuA4 (Figure 3H). The
effectiveness of ChIP assays and genome-wide location analysis
currently relies on validated antibodies to target proteins, which
vary greatly. Thus, the use of a common tag added on endoge-
nous proteins will greatly enhance reproducibility and, impor-
tantly, enable accurate comparison between different sets of
factors in distinct growth conditions (Bradbury and Pl€uckthun,
2015; Venters et al., 2011).
Purification of Endogenous DNA Repair Complexes
To further exemplify the robustness of our strategy, we extended
our studies to proteins involved in DNA repair. The Fanconi ane-
mia (FA) core complex is a multisubunit ubiquitin ligase that ini-
tiates DNA repair of interstrand crosslinks (Walden and Deans,
2014). Based on the work of several groups, its subunit compo-
sition has been well established and the core was defined as
containing FANCA, FANCB, FANCC, FANCE, FANCF, FANCG,
FANCL, FAAP20, and FAAP100 (Walden and Deans, 2014).
However, some variations in its architecture are observed, sug-
gesting that the complex is composed of submodules (Ali et al.,(E) Silver-stained SDS-PAGE showing the purified EZH2 complex expressed fro
expressing tag-EZH2 (#63). Proteins were identified from unfractionated protein s
and predicted molecular weights.
(F) Western blots of selected PRC2 subunits on purified fractions shown in (D) a
(G) Autoradiogram showing the results of anHMT assay used to determine the spe
for histones.
(H) Binding of endogenously tagged EZH2 and EPC1 to target gene promoters a
Values are expressed as % of input chromatin. Error bars indicate the SD from t
C2012; Rajendra et al., 2014; Walden and Deans, 2014). We at-
tempted to purify the FA core complex through the FANCF pro-
tein, as it is suggested to act as a scaffolding subunit. We tagged
the N terminus of FANCF using the CRISPR/Cas9 double-nick-
ing strategy and selected a homozygote clone expressing exclu-
sively the tagged FANCF protein for TAP (Ran et al., 2013) (Fig-
ures 4A–4C and S5). In this experiment, 5% (5/96, including 2
homozygous clones) of screened clones had a tagged allele.
Our approach successfully resulted in the purification of a core
complex that is highly similar to previously reported assemblies
(Figure 4D; Table S3) (Ali et al., 2012; Rajendra et al., 2014). In
addition, subunits of the anchor complex (FANCM, FAAP24,
and FAAP16) were detected with the core complex in cells under
normal cycling conditions (Walden and Deans, 2014) (Table S3).
Next, we attempted to purify minichromosome maintenance
complex component 8 (MCM8), a protein evolutionarily related
tomembers of theMCM2–7 replicative helicase family (Maiorano
et al., 2006). MCM8 has previously been shown to promote
homologous recombination via its interaction with MCM9, but
it is unknown whether this association is exclusive (Lutzmann
et al., 2012; Nishimura et al., 2012; Park et al., 2013). C-terminal
tagging of MCM8 clearly revealed the strict heterodimeric nature
of the complex (Figures 5 and S5; Table S4). Taken together,
these findings establish the value of using nuclease-mediated
endogenous gene tagging to refine the composition and enzy-
matic activities of protein complexes and highlight the robust-
ness of our TAP strategy.
Toward High-Throughput Genome-Scale Purification of
Native Endogenous Protein Complexes
The combined robustness of the endogenous targeting and pu-
rification methods lead us to test whether it was possible to pu-
rify the native protein complexes from the pool of cells shortly
after transfection. If such a scheme were successful, then it
would offer the unique opportunity to easily and rapidly tag all
human genes at their genomic location and isolate complexes.
We transfected cells with the EP400 CRISPR/Cas9 nuclease
and donor vectors and expanded cells for 7 days before harvest-
ing them for TAP purification (Figure 6A). Over the course of the
experiment, we monitored the presence of targeted alleles in the
cell population via PCR (Figures 6B and 6C). The EP400 complex
could be efficiently purified from whole-cell extracts with all
its associated subunits (Figure 6D). Then, we confirmed this
observation with the EZH2 reagents and obtained an almost
pure complex 10 days post-transfection (Figures 6E–6G). It is
critical to mention that no selection or cell sorting was used to
enrich for tagged cells in the population before attempting
the purifications. Thus, the requirement to generate genome-edi-
ted cell clones can be bypassed such that protein complexesm the endogenous locus. Wild-type K562 cells (Mock) and a clonal cell line
amples and assigned to specific gel bands based on western blotting analysis
nd (E).
cificity of the EZH2 complex. Coomassie staining was used as a loading control
s determined by ChIP-qPCR analysis.
wo independently performed experiments. See also Figure S4.
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Figure 4. Tandem Affinity Purification of
Endogenously Tagged Fanconi Anemia
Core Complex
(A) Strategy for CRISPR/Cas9-driven insertion of
the TAP tag to the N terminus of the FANCF pro-
tein. Schematic of the FANCF locus, Cas9 double
nickase target sites, and donor construct. The
positions of the start codon (ATG) and protospacer
adjacent motifs (PAMs) that specify nicking sites
are shown.
(B) Schematic and results of a PCR-based assay
(out-out PCR) to detect targeted integration (TI) of
the tag sequence in single-cell-derived clones
obtained by limiting dilution following CRISPR/
Cas9-driven gene targeting. Primers are located
outside of the homology arms and are designed to
yield a longer PCR product if the tag is inserted.
(C) Western blots showing tag-FANCF protein
expression in K562 clones. Mock indicates cells
treated with GFP expression vector. The FLAGM2
antibody was used to detect FANCF, and the
tubulin antibody was used as a loading control.
(D) Silver-stained SDS-PAGE showing the purified
FANCF complex. Wild-type K562 cells (Mock) and
clonal cell line expressing tag-FANCF (#12). Pro-
teins were identified from unfractionated protein
samples and assigned to specific gel bands based
predicted molecular weights.
See also Figure S5.can be directly isolated from gene-modified cell pools. These
data constitute a blueprint for high-throughput genome-scale
charting of physiological protein-protein interactions in human
cells.
DISCUSSION
Uses and Limitations of the AAVS1 Safe Harbor Ectopic
Expression System
Themethods described here offer unique advantages over tradi-
tional approaches used to study protein complexes in metazoan
cells. The purification strategy allows the identification of associ-
ated proteins by mass spectrometry, and the purity and yields of
the preparations are sufficient to perform enzymatic and mech-
anistic studies in vitro. It is worth noting that gene targeting at
AAVS1 can be performed in any human cell line since the
nuclease target site is naturally occurring, as compared to the
Flp-In system, which requires prior integration of a Flp recombi-
nation target (FRT) site into the genome. Biosafety issues asso-
ciated with the use of lentiviral vectors (Biosafety level 2 contain-
ment) are also avoided. Thus, it offers greater flexibility of use
than traditional ectopic expression systems used for proteomic
analysis. Note that ZFNs, TALENs, and CRISPR/Cas9 nucleases
targeting AAVS1 can be used interchangeably (Figure S1) (Hock-
emeyer et al., 2009; Hockemeyer et al., 2011; Mali et al., 2013).
The generation of cell lines expressing near-physiological levels
of bait proteins using the AAVS1 targeting system is straightfor-
ward and can be used to rapidly isolate a protein of interest and
perform reciprocal purifications in order to confirm the stable as-628 Cell Reports 13, 621–633, October 20, 2015 ª2015 The Authorssociation of a subunit with a protein complex. It can also be used
to generate panels of variants under isogenic settings and for the
analysis of specific splicing isoforms. As an example, the long
and short isoforms of JADE1 regulate the presence of ING4/5 tu-
mor suppressor proteins in the KAT7/HBO1 histone acetyltrans-
ferase complex (Figure S6) (Saksouk et al., 2009). One can also
contemplate using this system to test the function of several mu-
tants in the background of a cellular gene knockout. This could
be especially useful for the functional study of essential genes.
In addition, it offers a surrogate to study protein fusions resulting
from complex genomic rearrangements that cannot currently be
modeled via genome editing. As these protein fusions are often
‘‘toxic’’ when expressed in cells, we established a single-vector
autoregulated Tet-On expression system permitting tightly
controlled inducible expression of target proteins (Figure S6).
Of course, this system requires obtaining and subcloning the
cDNA of interest, which could be troublesome for very large pro-
teins. However, this does not seem to be amajor limitation, aswe
successfully purified the EP400 complex (400 kDa) and obtained
highly purified 350-kDa ataxia telangiectasia mutated (ATM) ki-
nase, a critical activator of the DNA damage response that is
notoriously challenging to purify (Figure S6) (Shiloh and Ziv,
2013). Importantly, the use of standard and characterized nucle-
ases can minimize the risk of confounding results due to off-
target mutagenesis.
Advantages and Limitations of Endogenous Tagging
Seamless tagging of genes at their natural chromosomal loca-
tions preserves the physiological regulation of bait protein
Figure 5. Tandem Affinity Purification of Endogenously Tagged Minichromosome Maintenance Complex Component 8
(A) Strategy for CRISPR/Cas9-driven insertion of the TAP tag to the C terminus of the MCM8 protein. Schematic of theMCM8 locus, wild-type Cas9 target site,
and donor construct. Annotated are the positions of the stop codon (TAA), target site, and protospacer adjacent motif (PAM) that specifies the cleavage site.
(B) Schematic and results of a PCR-based assay (in-out PCR) to detect targeted integration (TI) of the tag sequence in a single-cell-derived clone obtained by
limiting dilution following CRISPR/Cas9-driven gene targeting. In this particular case, one primer is located upstream of the left homology arm and one binds the
right homology arm to yield a longer PCR product if the tag is inserted.
(C) Western blots showing MCM8-tag protein expression in K562 clone #75. Mock indicates cells treated with donor and Cas9 nuclease in the absence of gRNA.
The FLAG M2 antibody was used to detect MCM8, and the GAPDH antibody was used as a loading control.
(D) Silver-stained SDS-PAGE showing the purified MCM8 complex. Wild-type K562 cells (Mock) and a clonal cell line expressing MCM8 tag (#75). Proteins were
identified from unfractionated protein samples and assigned to specific gel bands based on predicted molecular weights.
See also Figure S5.expression and its splicing variants. Since the epitope tag in-
serted is very small and not linked to a drug resistance gene or
other extraneous elements, natural 50 and 30 UTRs are minimally
perturbed and no sequence is lost. cis-acting regulatory ele-
ments aremaintainedwithin (introns) and outside (promoters/en-
hancers) transcribed regions. Thus, native regulatory mecha-
nisms of protein expression are retained, and the impact of
various stimuli that modulate isoform ratios and interactors can
be more precisely studied. Current limitations linked to constitu-
tive overexpression of bait proteins leading to higher rates of
false-positive and negative interactions are therefore avoided.
As examples, our approach settled the score on the KAT5 and
EP400 enzymatic activities, clearly establishing them as part of
a single stable macromolecular assembly in vivo. Moreover,
this approach led to the identification of MBTD1 as a novel sub-
unit of NuA4. It also demonstrates a direct physical link, in solu-
tion, between H3K27 and H3K9 histone methyltransferases, an
interaction previously suggested to occur only through colocali-
zation on the genome during development (Alekseyenko et al.,
2014). Histone and residue specificity of chromatin-modifying
enzymes has been marred on multiple occasions over the years
by several conflicting and debated results in the literature. Still
today, the specificity of many enzymes is up to interpretation.
We feel that our approach using endogenous activities along
with native substrates will lead to a more coherent picture help-
ing us to better understand the dynamic nature of the epigenome
during development and disease (Lalonde et al., 2014).CThe wide availability of research reagents for CRISPR/Cas9
and TALENs greatly facilitates the design and construction of
custom reagents. All nuclease-based reagents described here
were obtained from the plasmid repository Addgene.We provide
detailed examples of donor design (Figures S2, S4, and S5) in or-
der to facilitate the implementation and adaptation of the strat-
egy to user-specific contexts. The use of short homology arms
facilitates the construction of donor vectors, as they can be syn-
thesized as DNA fragments smaller than 1 kb in length. For se-
quences that are AT- or GC-rich, PCR-based amplification of
the homology arms might be required. Potential problems can
be encountered if highly repetitive elements are found in prox-
imity of the ATG or STOP codons, in which cases the length of
the arms should be truncated to avoid the presence of repeats
in the donor. However, this is not essential, as the MCM8 donor
described in this study contains repetitive elements and suc-
cessful targeting was achieved. Apart from strict biochemical
considerations, one should take into account the structure of
the gene, the various protein isoforms produced, and adjacent
genetic elements when choosing to tag either the 50 or 30 end
of genes.
A sensible preoccupation with genome editing techniques is
the possibility of off-target mutagenesis. In our experiments,
we used TALENs, wild-type Cas9, and Cas9 D10A (dual nickase)
interchangeably and did not observe overt toxicity or loss of tar-
geted cells. Continuing progress in the field aiming to increase
the precision of genome editing should progressively decreaseell Reports 13, 621–633, October 20, 2015 ª2015 The Authors 629
Figure 6. Efficient Complex Purification
from Unselected Gene-Modified Cell Pools
(A) Timeline of the experiment.
(B) Schematic of a PCR-based assay (out-out
PCR) to detect targeted integration (TI) of the tag
sequence at the C terminus of EP400. Primers are
located outside of the homology arms and are
designed to yield a longer PCR product if the tag is
inserted.
(C) Results of an out-out PCR assay conducted on
genomic DNA from K562 cells transfected with (1)
EGFP expression vector and EP400 donor (Mock)
and (2) wild-type Cas9 expression vector, gRNA
#3, and EP400 donor (EP400). Cells were
collected at various time points post-transfection.
(D) Silver-stained SDS-PAGE showing the purified
EP400 complex isolated from the cell pool 7 days
post-transfection.
(E) Same as in (B) but for the N-terminal tagging of
EZH2.
(F) Same as in (C) but using the EZH2 TALENs and
donor.
(G) Silver-stained SDS-PAGE showing the purified
EZH2 complex isolated from the cell pool 10 days
post-transfection. Proteins were identified from
unfractionated protein samples and assigned to
specific gel bands based on western blotting
analysis and predicted molecular weights.the risk of obtaining confounding results. However, we note that
the targeting specificity for the TAP tag using circular DNA do-
nors benefits from the fact that homology-directed repair
(HDR) mechanisms are required for integration of donor se-
quences. Thus, random integration of the donor is minimal,
because there are no homologous sequences at these potential
off-targets. Nevertheless, on-targetmutagenesis via non-homol-
ogous end joining (NHEJ) can result in small insertions and dele-
tions (indels) at the non-targeted allele, and care should be taken
to carefully genotype both tagged and untagged alleles in clon-
ally derived cells lines (see Figures S3 and S5 for examples). We
note that it is possible to design the targeting strategy to mini-
mize the potential impact of such mutagenic events (see Figures
S2, S4, and S5). In this study, we used clones with biallelic inte-
grations of the TAP tag when possible. This has an additional
advantage, as all molecules of the bait proteins are tagged in
the cell.630 Cell Reports 13, 621–633, October 20, 2015 ª2015 The AuthorsLastly, our data suggest that high-
throughput characterization of protein-
protein interactions under physiological
conditions is achievable, since protein
complexes can be efficiently purified
from mixed cell populations containing
only a fraction of tagged alleles (Fig-
ure 6). As genome-scale CRISPR-Cas9
knockout screening in human cells is
now a reality (Shalem et al., 2014;
Wang et al., 2014), it will be possible
to adapt these methods to generate
nucleases targeting either the N or C
terminus of every human protein. Thus,
a genome-scale proteomic approach of endogenous human
proteins using this strategy seems imminently feasible.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
K562 cells were obtained from the ATCC and maintained at 37C under 5%
CO2 in RPMI medium supplemented with 10% fetal bovine serum, penicillin-
streptomycin, and GlutaMAX. When cultivated in Erlenmeyer or spinner flasks,
25 mM HEPES-NaOH (pH 7.4) was added. Cells were transfected using the
Amaxa 4D-Nucleofector (Lonza) per the manufacturer’s recommendations.
ZFN, TALEN, and CRISPR/Cas9 Reagents
The AAVS1-targeting ZFNs and EZH2 TALENs (Addgene #36775 and #36776)
have been described previously (Hockemeyer et al., 2009; Reyon et al., 2012).
The cytomegalovirus (CMV)-driven human-codon optimized Cas9 nuclease
and nickase (Cas9 D10A) vectors (Addgene #41815 and #41816) and the
U6-driven guide RNA (gRNA) vector to target human AAVS1 (T2 target
sequence; Addgene #41818) have been described elsewhere (Mali et al.,
2013). The two U6-driven guide RNA (gRNA) vectors to target human FANCF
have been described previously (Tsai et al., 2014). All other gRNA expression
vectors were built in the MLM3636 (Addgene #43860) backbone. Target
sequences for EPC1 (50-GTGACGTAGCTTCCTCCGAG-30 ), EP400 (50-TG
CCCTGACTACTGGCACGG-30), MBTD1 (50-ATCAAACAAGAGCCATGAGG-
30), and MCM8 (50-CCAGCTTCAAACTATGTAAA-30) were chosen according
to a web-based CRISPR design tool (Hsu et al., 2013). The DNA sequence
for the gRNA for EP400, MBTD1, and MCM8 were modified at position 1 to
encode a ‘‘G’’ due to the transcription initiation requirement of the human U6
promoter. When present on a nuclease construct, FLAG epitopes were
removed by subcloning.
Construction of Plasmid Donors for Recombination
The AAVS1-TAP tagging plasmid (Addgene #68375) was assembled in the
AAVS1 SA-2A-puro-pA vector (Hockemeyer et al., 2009) by inserting a syn-
thetic DNA fragment containing a SV40 late polyadenylation sequence,
hPGK1 promoter, and TAP tag sequence in between the puromycin resistance
gene and the BGH polyadenylation site. The donor plasmids for tagging EPC1,
EP400, MBTD1, EZH2, and FANCF were synthesized as gBlocks gene frag-
ments (Integrated DNA Technologies) and assembled using the Zero Blunt
TOPO cloning kit (Life Technologies) or cloned by restriction into pUC19.
The homology arms for the MCM8 donor plasmid were amplified by PCR
from K562 genomic DNA.
Targeted Integration to the AAVS1 Locus
One million cells were transfected with 1 mg ZFN expression vector and 4 mg
donor constructs. Simultaneous selection and cloning was performed for
10 days in methylcellulose-based semi-solid RPMI medium supplemented
with 0.25 mg/ml puromycin starting 3 days post-transfection. Clones were
picked and expanded in 96 wells for 3 days and transferred to 12-well plates
for another 3 days before cells were harvested for western blot.
CRISPR/Cas9 and TALEN-Driven Targeted Integration
For targeting with the CRISPR/Cas9 system, onemillion cells were transfected
with 2 mg gRNA plasmid, 2 mg Cas9 vector, and 4 mg donor. For TALEN-driven
integration, 2.5 mg of each vector and 4 mg donor were transfected. Limiting
dilution cloning was performed 3 days post-transfection, and targeted clones
were identified via out-out PCR. For the experiments shown in Figure 6,
3million cells were transfected at the same DNA ratios and the cells were culti-
vated in 10ml RPMImedia in a T-75 flask for 3 days. The cells were then diluted
to 2E5/ml and grown in Erlenmeyer flasks with agitation until they reached a
density of 1E6/ml. Under these conditions, we typically obtained 2E8 cells
(200 ml culture at saturation) 7 days post-transfection and 1E9 cells (1 l culture
at saturation) 10 days post-transfection.
TAP
Typically, nuclear extracts (Abmayr et al., 2006) were prepared from 1E9 to 3E9
cells (1 l to 3 l cultures at saturation), adjusted to 0.1%Tween-20, and ultracen-
trifuged at 100,000 3 g for 45 min. Extracts were precleared with 300 ml Se-
pharose CL-6B (Sigma), then 250 ml anti-FLAG M2 affinity resin (Sigma) was
added for 2 hr at 4C. The beads were then washed in Poly-Prep columns
(Bio-Rad) with 40 column volumes (CV) of buffer #1 (20 mM HEPES-KOH
[pH 7.9], 10% glycerol, 300 mM KCl, 0.1% Tween 20, 1 mM DTT, 13 Halt pro-
tease and phosphatase inhibitor cocktail without EDTA [Pierce]) followed by 40
CV of buffer #2 (20 mM HEPES-KOH [pH 7.9], 10% glycerol, 150 mM KCl,
0.1% Tween 20, 1mMDTT, 13Halt protease and phosphatase inhibitor cock-
tail without EDTA [Pierce]). Complexes were eluted with 5 CV of buffer #2
supplemented with 150 mg/ml 3xFLAG peptide (Sigma) for 1 hr at 4C. Next,
fractions were mixed with 125 ml Strep-Tactin Sepharose (IBA) affinity matrix
for 1 hr at 4C, and the beads were washed with 40 CV of buffer #2 in Poly-
Prep columns (Bio-Rad). Complexes were eluted in two fractions with 4 CV
of buffer #2 supplemented with 2.5 mMD-biotin, flash frozen in liquid nitrogen,
and stored at80C. Typically, 15 ml of the first elution (3%of total) was loaded
on Bolt or NuPAGE 4%–12%Bis-Tris gels (Life Technologies) and analyzed by
silver staining. For purifications from whole-cell extracts, cells were washed
twice with PBS and lysed in buffer A (20 mM HEPES-KOH [pH 7.9], 10% glyc-
erol, 300 mM KCl, 0.1% IGEPAL CA-630, 1 mM DTT, 13 Halt protease andCphosphatase inhibitor cocktail without EDTA [Pierce]) (ratio of 100 ml of lysis
buffer per 1E6 cells) for 30 min at 4C. Extracts were centrifuged for 30 min
at 17,000 3 g, and the purifications were performed as described above.
HAT and HMT Assays
TAP-purified fractions were assayed for enzymatic activity on short oligonu-
cleosomes isolated from HeLa S3 cells as described previously (Doyon
et al., 2004; Musselman et al., 2012).
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